Prestwick Pharmaceuticals, Inc. Withdraws IPO

WASHINGTON, Dec 20 (Reuters) - Prestwick Pharmaceuticals Inc., whose drug products target chronic diseases of the central nervous system, on Tuesday withdrew its planned initial public offerings due to market conditions.

MORE ON THIS TOPIC